Drug Database
L01FA01 rituximab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM MabThera 100mg and 500mg Concentrate for Solution for Infusion
- POM MabThera 1400 mg Solution for Subcutaneous Injection
- POM Rixathon 100 mg concentrate for solution for infusion (Great Britain) ▼
- POM Rixathon 500 mg concentrate for solution for infusion (Great Britain) ▼
- POM Ruxience 100 mg concentrate for solution for infusion ▼
- POM Ruxience 500 mg concentrate for solution for infusion ▼
- POM Truxima 100 mg and 500 mg concentrate for solution for infusion ▼
- POM Truxima 500 mg concentrate for solution for infusion ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).